hnc042
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 9, 2018 (NCT03740555)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusINHIBITOR
Influenza A virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04603989 | Phase 1 | Aug 3, 2020 | Guangzhou Henovcom Bioscience Co. Ltd., Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., Nanjing Medical University |
| NCT03740555 | Phase 1 | Nov 9, 2018 | Guangzhou Henovcom Bioscience Co. Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Henovcom Bioscience Co. Ltd. | For profit | 2 | 2 | 1 | 2018 |
| Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1